TOVX – theriva biologics, inc. (US:NASDAQ)
Stock Stats
News
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026
Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Form PRE 14A Theriva Biologics, Inc. For: Mar 04
Form 8-K Theriva Biologics, Inc. For: Feb 17
Form 8-K Theriva Biologics, Inc. For: Feb 11
Form 8-K Theriva Biologics, Inc. For: Jan 12
Form 4 Theriva Biologics, Inc. For: Jan 05 Filed by: SHALLCROSS STEVEN A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.